Jiayi (Angela) Xiao, Cpa
About Jiayi (Angela) Xiao, Cpa
Jiayi (Angela) Xiao is an Assistant Controller with extensive experience in SEC reporting and assurance roles. She has worked for notable companies such as EY, Pfizer, and Global Blood Therapeutics, and holds a degree in Business Administration and Accounting from the University of Southern California.
Current Position at Octant
Jiayi (Angela) Xiao serves as the Assistant Controller at Octant, a position she has held since 2023. In this role, she is responsible for overseeing financial reporting and ensuring compliance with accounting standards. Her experience in financial management contributes to the company's operational efficiency and strategic financial planning.
Previous Experience at Global Blood Therapeutics
Before joining Octant, Jiayi worked at Global Blood Therapeutics as Senior Manager of SEC Reporting from 2021 to 2022. In this role, she managed the preparation and filing of financial reports with the Securities and Exchange Commission, ensuring adherence to regulatory requirements. Her contributions supported the company's financial transparency and accountability.
Professional Background at EY
Jiayi has extensive experience at Ernst & Young (EY), where she held multiple positions from 2015 to 2021. She began as an Assurance Intern for two months in 2015, then progressed to Assurance Staff from 2016 to 2018, Assurance Senior from 2018 to 2020, and Assurance Manager from 2020 to 2021. Her roles involved auditing financial statements and providing assurance services to clients, enhancing her expertise in financial compliance.
Education and Academic Background
Jiayi studied at the University of Southern California from 2011 to 2015, earning a degree in Business Administration and Accounting, with a minor in Psychology. Additionally, she attended HEC Paris in 2015, furthering her education in a prestigious international setting. This academic foundation supports her professional roles in finance and accounting.
Experience at Pfizer
Jiayi worked at Pfizer as Senior Manager of SEC Reporting from 2022 to 2023. In this capacity, she was responsible for managing SEC filings and ensuring compliance with financial reporting standards. Her role at Pfizer further solidified her expertise in regulatory reporting within the pharmaceutical industry.